Skip to main content
Log in

Pharmacokinetics of Anorectal Nifedipine and Lidocaine (Lignocaine) Ointment following Haemorrhoidectomy

An Open-Label, Single-Dose, Phase IV Clinical Study

  • Original Research Article
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

Abstract

Objectives: This study aimed to assess whether topical anorectal application of an ointment containing nifedipine (0.3% w/w) and lidocaine (lignocaine) [1.5% w/w] to patients undergoing Milligan-Morgan haemorrhoidectomy achieves pharmacologically relevant serum concentrations of the active ingredients and has any haemodynamic effects or adverse effects.

Methods: A single dose of 3 g of study ointment was circumferentially applied inside the anus to 24 patients (17 males and 7 females) aged 23–71 years (mean ± SD: 42.9 ± 4.9 years) during postoperative dressing after Milligan-Morgan haemorrhoidectomy from March 2007 to January 2008. Blood samples for the determination of nifedipine and lidocaine serum concentrations were drawn before surgery and at 20, 40, 60, 90, 120, 240, 360, 480 and 720 minutes after application. Serum concentrations of nifedipine and lidocaine were determined by a high-performance liquid chromatography method in order to calculate pharmacokinetic parameters. Patients’ BP, heart rate and ECG readings were monitored during the study.

Results: Chromatographic signals of nifedipine were sporadically observed in only five patients (20.8%), consistent with therapeutically negligible concentrations and insufficient to permit calculation of any pharmacokinetic parameters. The serum concentrations of nifedipine in these five patients ranged from 5.9 to 18.8 ng/mL. Lidocaine concentrations were detectable in all patients. The means ± SD and medians of pharmacokinetic parameters for lidocaine were as follows: maximum serum concentration (Cmax) 245.1±370.8 ng/mL, 73.6 ng/mL; time to reach Cmax (tmax) 69.2±78.3 minutes, 40 minutes; area under the serum concentration-time curve from 0 to 6 hours (AUC6) 756.5±1254.1 ng·h/mL, 238.2 ng·h/mL. Only three patients had maximum serum concentrations above 1000 ng/mL (1037.8, 1044.75 and 1364.1 ng/mL). These outlier concentrations were four to five times lower than the threshold of CNS lidocaine toxicity (5000–6000 ng/mL). No serious local or systemic adverse events were observed throughout the study, and no subjects developed arrhythmias or significant ECG changes. Neither BP nor mean heart rate varied significantly after application of a single dose.

Conclusions: This study demonstrates that single-dose topical application of an ointment containing nifedipine (0.3% w/w) and lidocaine (1.5% w/w) to patients undergoing Milligan-Morgan haemorrhoidectomy is safe to use. Following application onto damaged anorectal mucosa, nifedipine and lidocaine are absorbed into the bloodstream in small quantities that do not have any major implications for the safety of the product. Further studies are required to evaluate nifedipine and lidocaine concentrations in serum using a multiple-dose regimen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table I
Table II
Table III
Table IV
Table V
Table VI
Fig. 1

Similar content being viewed by others

References

  1. Nisar PJ, Scholefield JH. Managing haemorrhoids. BMJ 2003; 327: 847–51

    Article  PubMed  Google Scholar 

  2. Goldstein ET, Williamson PR, Larach SW. Subcutaneous morphine pump for postoperative hemorrhoidectomy pain management. Dis Colon Rectum 1993; 36: 439–46

    Article  PubMed  CAS  Google Scholar 

  3. Carapeti E, Kamm M, McDonald P, et al. Double-blind randomised controlled trial of effect of metronidazole on pain after day-case haemorrhoidectomy. Lancet 1998; 351: 169–72

    Article  PubMed  CAS  Google Scholar 

  4. Wasvary HJ, Hain J, Mosed-Vogel M, et al. A randomized, prospective, double-blind, placebo-controlled trial of effect of nitroglycerin ointment on pain after hemorrhoidectomy. Dis Colon Rectum 2001; 44: 1069–73

    Article  PubMed  CAS  Google Scholar 

  5. Deutsch AA, Moshkovitz M, Nudelman I, et al. Anal pressure measurements in the study of hemorrhoid etiology and their relation to treatment. Dis Colon Rectum 1987; 30: 855–7

    Article  PubMed  CAS  Google Scholar 

  6. Roe AM, Bartolo DC, Vellacott KD, et al. Submucosal versus ligation excision haemorrhoidectomy: a comparison of anal sensation, anal sphincter manometry and postoperative pain and function. Br J Surg 1987; 74: 948–51

    Article  PubMed  CAS  Google Scholar 

  7. Kanellos I, Zacharakis E, Christoforidis E, et al. Usefulness of lateral internal sphincterotomy in reducing postoperative pain after open hemorrhoidectomy. World J Surg 2005; 29: 464–8

    Article  PubMed  Google Scholar 

  8. Goligher JC, Graham NG, De Dombal FT, et al. The value of stretching of anal sphincters in the relief of pain after haemorrhoidectomy [abstract]. Br J Surg 1969; 56: 390

    Article  PubMed  CAS  Google Scholar 

  9. Ho YH, Seow-Choen F, Low JY, et al. Randomised controlled trial of trimebutine (anal sphincter relaxant) for pain after haemorrhoidectomy. Br J Surg 1997; 84: 377–9

    Article  PubMed  CAS  Google Scholar 

  10. Davies J, Duffy D, Boyt N, et al. Botulinum toxin (botox) reduces pain after hemorrhoidectomy: results of a double-blind, randomized study. Dis Colon Rectum 2003; 46: 1097–102

    Article  PubMed  Google Scholar 

  11. Nicholson TJ, Armstrong D. Topical metronidazole (10 percent) decreases posthemorrhoidectomy pain and improves healing. Dis Colon Rectum 2004; 47: 711–6

    Article  PubMed  Google Scholar 

  12. Vinson-Bonnet B, Coltat JC, Fingerhut A, et al. Local infiltration with ropivacaine improves immediate postoperative pain control after hemorrhoidal surgery. Dis Colon Rectum 2002; 45: 104–8

    Article  PubMed  Google Scholar 

  13. Coskun A, Duzgun SA, Uzunkoy A, et al. Nitroderm TTS® band application for pain after hemorrhoidectomy. Dis Colon Rectum 2001; 44: 680–5

    Article  PubMed  CAS  Google Scholar 

  14. Colak T, Akca T, Dirlik M, et al. Micronized flavonoids in pain control after hemorrhoidectomy: a prospective randomized controlled study. Surg Today 2003; 33: 828–32

    Article  PubMed  CAS  Google Scholar 

  15. Elton C, Sen P, Montgomery AC. Initial study to assess the effects of topical glyceryl trinitrate for pain after haemorrhoidectomy. Int J Surg Investig 2001; 2: 353–7

    PubMed  CAS  Google Scholar 

  16. Chrysos E, Xynos E, Tzovaras G, et al. Effect of nifedipine on rectoanal motility. Dis Colon Rectum 1996; 39: 212–6

    Article  PubMed  CAS  Google Scholar 

  17. Antropoli C, Perrotti P, Rubino M, et al. Nifedipine for local use in conservative treatment of anal fissures: preliminary results of a multicenter study. Dis Colon Rectum 1999; 42: 1011–5

    Article  PubMed  CAS  Google Scholar 

  18. Ezri T, Susmallian S. Topical nifedipine vs. topical glyceryl trinitrate for treatment of chronic anal fissure. Dis Colon Rectum 2003; 46: 805–8

    Article  PubMed  Google Scholar 

  19. Perrotti P, Antropoli C, Noschese G, et al. Topical nifedipine for conservative treatment of acute haemorrhoidal thrombosis. Colorectal Dis 2000; 2: 18–21

    Article  Google Scholar 

  20. Cook TA, Brading AF, Mortensen NJ. Effects of nifedipine on anorectal smooth muscle in vitro. Dis Colon Rectum 1999; 42: 782–7

    Article  PubMed  CAS  Google Scholar 

  21. Cook TA, Brading AF, Mortensen NJ. Differences in contractile properties of anorectal smooth muscle and the effects of calcium channel blockade. Br J Surg 1999; 86: 70–5

    Article  PubMed  CAS  Google Scholar 

  22. Perrotti P, Bove A, Antropoli C, et al. Topical nifedipine with lidocaine ointment versus active control for treatment of chronic anal fissure: results of a prospective, randomized, double-blind study. Dis Colon Rectum 2002; 45: 1468–75

    Article  PubMed  Google Scholar 

  23. Perrotti P, Antropoli C, Molino D, et al. Conservative treatment of acute thrombosed external hemorrhoids with topical nifedipine. Dis Colon Rectum 2001; 44: 405–9

    Article  PubMed  CAS  Google Scholar 

  24. Perrotti P, Grumetto L, Barbato F, et al. Serum levels and possible haemodynamic effects following anorectal application of an ointment containing nifedipine and lignocaine: a study in healthy volunteers. Clin Drug Invest 2006; 26: 459–67

    Article  CAS  Google Scholar 

  25. Raemsch KD, Sommer J. Pharmacokinetics and metabolism of nifedipine. Hypertension 1983; 5: 18–24

    CAS  Google Scholar 

  26. Traube M, Hongo M, McAllister Jr RG, et al. Correlation of plasma levels of nifedipine and cardiovascular effects after sublingual dosing in normal subjects. J Clin Pharmacol 1985; 25: 125–9

    PubMed  CAS  Google Scholar 

  27. Kurosawa S, Kurosawa N, Owada E, et al. Rectal administration of nifedipine: hemodynamic effects and pharmacokinetics in hypertensives. J Int Med Res 1987; 15: 121–7

    PubMed  CAS  Google Scholar 

  28. Kleinbloesem CH, van Harten J, de Leede LG, et al. Nifedipine kinetics and dynamics during rectal infusion to steady state with an osmotic system. Clin Pharmacol Ther 1984; 36: 396–4

    Article  PubMed  CAS  Google Scholar 

  29. Covino BG. Toxicity of local anesthetic agents. Acta Anaesthesiol Belg 1988; 39(3 Suppl. 2): 159–64

    PubMed  CAS  Google Scholar 

  30. Tucker GT. Clinical pharmacokinetics of local anesthetics. Clin Pharmacokinet 1979; 4: 241–78

    Article  PubMed  CAS  Google Scholar 

  31. Echizen H, Eichelbaum M. Clinical pharmacokinetics of verapamil, nifedipine and diltiazem. Clin Pharmacokinet 1986 Nov; 11(6): 425–49

    Article  PubMed  CAS  Google Scholar 

  32. Covino BG. Pharmacology of local anesthetics. Br J Anaesth 1986; 58: 701–16

    Article  PubMed  CAS  Google Scholar 

  33. Tonsuwannont W, Praisontarangkul OA, Manorot M, et al. Pharmacokinetics of oral lidocaine and nifedipine in patients with liver cirrhosis. J Med Assoc Thai 1996 May; 79(5): 309–19

    PubMed  CAS  Google Scholar 

  34. Hardman JG, Limbird LE, Molinoff PB, et al. Goodman & Gilman’s the pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill, 1996: 1195; 1754–65

    Google Scholar 

  35. Shiau JM, Su HP, Chen HS, et al. Use of a topical anesthetic cream (EMLA) to reduce pain after hemorrhoidectomy. Reg Anesth Pain Med 2008; 33: 30–5

    PubMed  CAS  Google Scholar 

  36. Vickers ER, Marziani N, Gerzina TM, et al. Pharmacokinetics of EMLA cream 5% application to oral mucosa. Anesth Prog 1997; 44: 32–7

    PubMed  CAS  Google Scholar 

  37. Leopold A, Wilson S, Weaver JS, et al. Pharmacokinetics of lidocaine delivered from a transmucosal patch in children. Anesth Prog 2002; 49: 82–7

    PubMed  Google Scholar 

  38. Jensen SL. Treatment of first episodes of acute anal fissure: prospective randomised study of lignocaine ointment versus hydrocortisone ointment or warm sitz baths plus bran. Br Med J (Clin Res Ed) 1986; 3(292): 1167–9

    Article  Google Scholar 

  39. McDonald P, Driscoll AM, Nicholls RJ. The anal dilator in the conservative management of acute anal fissures. Br J Surg 1983; 70: 25–6

    Article  PubMed  CAS  Google Scholar 

  40. Neiger A, Herms E. The symptomatic therapy of hemorrhoids and anal eczema: a report of experiences from proctology practice. Schweiz Rundsch Med Prax 1990; 79(31-32): 918–20

    PubMed  CAS  Google Scholar 

  41. Brown AC, Sumfest JM, Rozwadowski JV. Histopathology of the internal anal sphincter in chronic anal fissure. Dis Colon Rectum 1989; 32: 680–3

    Article  PubMed  CAS  Google Scholar 

  42. Benfeldt E, Serup J, Menné T. Effect of barrier perturbation on cutaneous salicylic acid penetration in human skin: in vivo pharmacokinetics using microdialysis and non-invasive quantification of barrier function. Br J Dermatol 1999; 140: 739–48

    Article  PubMed  CAS  Google Scholar 

  43. Jonas M, Barrett DA, Shaw PN, et al. Systemic levels of glyceryl trinitrate following topical application to the anoderm do not correlate with the measured reduction in anal pressure. Br J Surg 2001; 88: 1613–6

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

Bracco SpA, Milan, Italy, provided financial support for this phase IV clinical study subject to Good Clinical Practice rules, Italian laws and local ethics committee decisions. This financial support was limited to payment of health insurance policies for patients who participated in the trial, supplying investigational products and paying institutions for the costs of material used for every patient.

Pasquale Perrotti and Carmine Antropoli are general staff and colorectal surgeons at ‘A. Cardarelli’ Hospital, Naples, Italy. They wrote this article, are independent of any financial arrangement with the pharmaceutical company whose product was tested in this study, and have no conflicts of interest that are directly relevant to the content of this study. Guglielmo Giannotti carried out surgical procedures and clinical assessments for the evaluation of safety at the Second Department of Surgery, General Hospital of Crema, Crema, Italy, and has no conflicts of interest that are directly relevant to the content of this study. Mario Regazzi and Maria Cusato are the main investigators of a certified centre of Pharmacology — Clinical Pharmacokinetic Laboratory Department of Pharmacology, Foundation IRCCS, San Matteo General Hospital, Pavia, Italy, which carried out the determinations of nifedipine and lidocaine. These investigators have no conflicts of interest that are directly relevant to the content of this study. Enzo Grossi, Patrizia Dominici and Renata Cerutti are employees of/researchers for Bracco SpA. They played a role in planning and application of the methods protocol, coordination of the institutions involved in the study, and the statistical evaluation of data. These roles were limited by Good Clinical Practice rules and Italian laws.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pasquale Perrotti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Perrotti, P., Dominici, P., Grossi, E. et al. Pharmacokinetics of Anorectal Nifedipine and Lidocaine (Lignocaine) Ointment following Haemorrhoidectomy. Clin. Drug Investig. 29, 243–256 (2009). https://doi.org/10.2165/00044011-200929040-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00044011-200929040-00003

Keywords

Navigation